The Parker Institute   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4
Founded: San Francisco CA United States (2016)

Organization Overview

First Clinical Trial
2016
NCT03121547
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

CSO The Parker Institute | Parker Institute for Cancer Immunotherapy | The Parker institute | The Parker Institute